The FDA has approved dupilumab as the first targeted treatment for adults with bullous pemphigoid, showing improved remission rates and reduced corticosteroid use.
Low testosterone and insufficient sleep were both linked to higher odds of psoriasis in a U.S. population study, even after adjusting for age, BMI, and other factors.
A decade-long analysis tracked global trends, key authors, drug developments, and growing research volume in studies focused on atopic dermatitis-related itch.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A large international study found that psoriasis patients treated with biologic therapies had a significantly lower risk of cardiovascular disease compared to those receiving oral treatments.
The addition of methotrexate to adalimumab for the treatment of plaque psoriasis may not improve drug survival, efficacy, or safety compared with adalimumab alone, according to a large real-world cohort study.
Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.
As America’s older adult population grows and geriatricians retire, nurse practitioners are stepping up to provide essential, compassionate care—often in patients’ homes.